GB0610706D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0610706D0
GB0610706D0 GB0610706A GB0610706A GB0610706D0 GB 0610706 D0 GB0610706 D0 GB 0610706D0 GB 0610706 A GB0610706 A GB 0610706A GB 0610706 A GB0610706 A GB 0610706A GB 0610706 D0 GB0610706 D0 GB 0610706D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0610706A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0610706A priority Critical patent/GB0610706D0/en
Publication of GB0610706D0 publication Critical patent/GB0610706D0/en
Priority to BRPI0620140-7A priority patent/BRPI0620140A2/en
Priority to KR1020087016946A priority patent/KR20080079675A/en
Priority to PCT/GB2006/004750 priority patent/WO2007071958A2/en
Priority to PT06820566T priority patent/PT1971338E/en
Priority to AU2006328189A priority patent/AU2006328189B2/en
Priority to JP2008546586A priority patent/JP5167144B2/en
Priority to DE602006020621T priority patent/DE602006020621D1/en
Priority to AT06820566T priority patent/ATE500832T1/en
Priority to US12/158,264 priority patent/US20080269261A1/en
Priority to SI200630997T priority patent/SI1971338T1/en
Priority to CA002631764A priority patent/CA2631764A1/en
Priority to EP06820566A priority patent/EP1971338B8/en
Priority to PL06820566T priority patent/PL1971338T3/en
Priority to DK06820566.5T priority patent/DK1971338T3/en
Priority to NZ568811A priority patent/NZ568811A/en
Priority to IL191796A priority patent/IL191796A0/en
Priority to NO20082567A priority patent/NO20082567L/en
Priority to HK09100369.4A priority patent/HK1123186A1/en
Priority to US12/892,478 priority patent/US20110212978A1/en
Priority to HR20110360T priority patent/HRP20110360T1/en
Priority to CY20111100546T priority patent/CY1111547T1/en
Ceased legal-status Critical Current

Links

GB0610706A 2005-12-22 2006-05-31 Combination therapy Ceased GB0610706D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GB0610706A GB0610706D0 (en) 2006-05-31 2006-05-31 Combination therapy
NZ568811A NZ568811A (en) 2005-12-22 2006-12-19 Combination of ZD6474 and pemetrexed for treating cancer and the like
SI200630997T SI1971338T1 (en) 2005-12-22 2006-12-19 Combination of zd6474 and pemetrexed
EP06820566A EP1971338B8 (en) 2005-12-22 2006-12-19 Combination of zd6474 and pemetrexed
PCT/GB2006/004750 WO2007071958A2 (en) 2005-12-22 2006-12-19 Combination of zd6474 and pemetrexed
PT06820566T PT1971338E (en) 2005-12-22 2006-12-19 Combination of zd6474 and pemetrexed
AU2006328189A AU2006328189B2 (en) 2005-12-22 2006-12-19 Combination of ZD6474 and pemetrexed
JP2008546586A JP5167144B2 (en) 2005-12-22 2006-12-19 Combination therapy
DE602006020621T DE602006020621D1 (en) 2005-12-22 2006-12-19 COMBINATION OF ZD6474 AND PEMETREXED
AT06820566T ATE500832T1 (en) 2005-12-22 2006-12-19 COMBINATION OF ZD6474 AND PEMETREXED
US12/158,264 US20080269261A1 (en) 2005-12-22 2006-12-19 Combination of Zd6474 and Pemetrexed
BRPI0620140-7A BRPI0620140A2 (en) 2005-12-22 2006-12-19 use of zd6474 or a pharmaceutically acceptable salt thereof and pemetrexed, pharmaceutical composition, kit, and method for producing an antiangiogenic and / or vascular permeability reducing effect
CA002631764A CA2631764A1 (en) 2005-12-22 2006-12-19 Combination of zd6474 and pemetrexed
KR1020087016946A KR20080079675A (en) 2005-12-22 2006-12-19 Combination of zd6474 and pemetrexed
PL06820566T PL1971338T3 (en) 2005-12-22 2006-12-19 Combination of zd6474 and pemetrexed
DK06820566.5T DK1971338T3 (en) 2005-12-22 2006-12-19 Combination of ZD6474 and pemetrexed
IL191796A IL191796A0 (en) 2005-12-22 2008-05-28 Combination of zd6474 and pemetrexed
NO20082567A NO20082567L (en) 2005-12-22 2008-06-02 Combination of ZD6474 and pemetrexed
HK09100369.4A HK1123186A1 (en) 2005-12-22 2009-01-14 Combination of zd6474 and pemetrexed zd6474
US12/892,478 US20110212978A1 (en) 2005-12-22 2010-09-28 Combination of ZD6474 and Pemetrexed
HR20110360T HRP20110360T1 (en) 2005-12-22 2011-05-16 Combination of zd6474 and pemetrexed
CY20111100546T CY1111547T1 (en) 2005-12-22 2011-06-08 COMBINATION ZD6474 AND PERMETRIC

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0610706A GB0610706D0 (en) 2006-05-31 2006-05-31 Combination therapy

Publications (1)

Publication Number Publication Date
GB0610706D0 true GB0610706D0 (en) 2006-07-12

Family

ID=36694650

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0610706A Ceased GB0610706D0 (en) 2005-12-22 2006-05-31 Combination therapy

Country Status (1)

Country Link
GB (1) GB0610706D0 (en)

Similar Documents

Publication Publication Date Title
IL196559A0 (en) Combination therapy
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
IL196556A0 (en) Combination therapy
GB2436010B (en) Therapy device
GB0601962D0 (en) Therapeutic agents
GB0624874D0 (en) Treatment
IL199992A0 (en) Combination therapy
EP2054061A4 (en) Combination therapy
GB0616214D0 (en) Therapeutic Agents
GB0611152D0 (en) Therapeutic agents
GB0504206D0 (en) Combination therapy
GB0719518D0 (en) Therapy
GB0620818D0 (en) Therapeutic agents
IL198026A0 (en) Sequential combination therapy
GB0620059D0 (en) Therapeutic agents
ZA200902203B (en) Combination therapy
GB0609676D0 (en) Therapeutic agents
EP2211863A4 (en) Combination therapy
GB0700284D0 (en) Combination therapy
GB0604460D0 (en) Treatment
GB0622195D0 (en) Therapeutic agents
GB0606660D0 (en) Targeted Therapy
GB0716072D0 (en) Therapy
GB0700635D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)